Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC)

CUSIP: 359616109

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
66,594,760
Total 13F shares
55,518,138
Share change
-4,894,476
Total reported value
$183,197,485
Put/Call ratio
10%
Price per share
$3.30
Number of holders
85
Value change
-$14,257,183
Number of buys
41
Number of sells
73

Security key

359616109

Report period

Q2 2023

Institutions

85

Top holders

10

Top shareholders of FULC - Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
RA CAPITAL MANAGEMENT, L.P.
13F
Company
17%
11,609,704
$33,087,656 31 Mar 2023
13F
FMR LLC
13F
Company
9.2%
6,156,328
$17,545,535 31 Mar 2023
13F
RTW INVESTMENTS, LP
13F
Company
8.3%
5,511,839
$15,708,741 31 Mar 2023
13F
SUVRETTA CAPITAL MANAGEMENT, LLC
13F
Company
7.8%
5,177,710
$14,756,474 31 Mar 2023
13F
Third Rock Ventures III, L.P.
3/4/5
10%+ Owner
class O/S missing
4,305,356
$14,250,729 13 Dec 2022
Mark J. Levin
3/4/5
Director, 10%+ Owner
class O/S missing
4,038,002
$13,365,787 10 Nov 2021
BlackRock Finance, Inc.
13F
Company
6.3%
4,183,738
$11,923,654 31 Mar 2023
13F
VANGUARD GROUP INC
13F
Company
4.3%
2,878,491
$8,203,699 31 Mar 2023
13F
Point72 Asset Management, L.P.
13F
Company
4%
2,643,672
$7,534,465 31 Mar 2023
13F
TRV GP IV, LLC
13F
Company
3.5%
2,343,154
$6,677,989 31 Mar 2023
13F
COWEN AND COMPANY, LLC
13F
Company
3.3%
2,176,045
$6,201,728 31 Mar 2023
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.7%
1,806,422
$5,148,303 31 Mar 2023
13F
VR Adviser, LLC
13F
Company
2%
1,307,094
$3,725,218 31 Mar 2023
13F
MORGAN STANLEY
13F
Company
1.7%
1,162,368
$3,312,749 31 Mar 2023
13F
Cormorant Asset Management, LP
13F
Company
1.6%
1,081,490
$3,082,000 31 Mar 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.6%
1,062,634
$3,028,506 31 Mar 2023
13F
STATE STREET CORP
13F
Company
1.4%
965,588
$2,751,926 31 Mar 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.1%
754,886
$2,151,393 31 Mar 2023
13F
Rock Springs Capital Management LP
13F
Company
1.1%
727,673
$2,073,868 31 Mar 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.98%
649,810
$1,851,959 31 Mar 2023
13F
Simplify Asset Management Inc.
13F
Company
0.96%
639,118
$1,821,486 31 Mar 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.93%
620,559
$1,769,000 31 Mar 2023
13F
Vivo Capital, LLC
13F
Company
0.83%
550,000
$1,567,500 31 Mar 2023
13F
NORTHERN TRUST CORP
13F
Company
0.68%
451,952
$1,288,063 31 Mar 2023
13F
HARVARD MANAGEMENT CO INC
13F
Company
0.62%
410,714
$1,170,535 31 Mar 2023
13F
NORGES BANK
13F
Company
0.62%
410,500
$1,169,925 31 Mar 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.59%
390,100
$1,112,000 31 Mar 2023
13F
Squarepoint Ops LLC
13F
Company
0.48%
319,711
$911,176 31 Mar 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.45%
297,811
$848,762 31 Mar 2023
13F
Nuveen Asset Management, LLC
13F
Company
0.43%
288,737
$823,000 31 Mar 2023
13F
BESSEMER GROUP INC
13F
Company
0.43%
286,988
$818,000 31 Mar 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.39%
262,600
$748,410 31 Mar 2023
13F
Bank of New York Mellon Corp
13F
Company
0.32%
212,201
$604,773 31 Mar 2023
13F
CITADEL ADVISORS LLC
13F
Company
0.31%
209,459
$596,958 31 Mar 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.29%
190,269
$543,000 31 Mar 2023
13F
Alyeska Investment Group, L.P.
13F
Company
0.23%
152,148
$433,622 31 Mar 2023
13F
Graham Capital Management, L.P.
13F
Company
0.22%
146,979
$418,890 31 Mar 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.21%
141,311
$402,736 31 Mar 2023
13F
FIDUCIARY TRUST CO
13F
Company
0.21%
136,555
$389,182 31 Mar 2023
13F
XTX Topco Ltd
13F
Company
0.19%
123,768
$352,739 31 Mar 2023
13F
MARSHALL WACE, LLP
13F
Company
0.18%
121,000
$344,850 31 Mar 2023
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.14%
94,770
$270,095 31 Mar 2023
13F
S.c.a. Candriam
13F
Individual
0.15%
101,337
$265,829 31 Mar 2023
13F
Swiss National Bank
13F
Company
0.13%
86,500
$246,525 31 Mar 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.11%
75,507
$215,000 31 Mar 2023
13F
Cubist Systematic Strategies, LLC
13F
Company
0.1%
65,076
$185,467 31 Mar 2023
13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)
13F
Company
0.09%
62,274
$177,481 31 Mar 2023
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.09%
59,067
$168,341 31 Mar 2023
13F
Tekla Capital Management LLC
13F
Company
0.09%
58,537
$166,830 31 Mar 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.08%
55,900
$159,315 31 Mar 2023
13F

Institutional Holders of Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) as of Q2 2023

As of 30 Jun 2023, Fulcrum Therapeutics, Inc. - Common stock, par value $0.001 per share (FULC) was held by 85 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,518,138 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, FMR LLC, COWEN AND COMPANY, LLC, VANGUARD GROUP INC, TRV GP IV, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Point72 Asset Management, L.P., and BlackRock Inc.. This page lists 85 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders
115
Q2 2023 holders
85
Holder diff
-30
Investor Q1 2023 Shares Q2 2023 Shares Share Diff Share Chg % Q1 2023 Value $ Q2 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .